BeStock  
Stocks › Biotechnology › LTGO

Latigo Biotherapeutics LTGO

US equityMarket cap rank #3223Biotechnology
$15.52 −$0.74 (-4.55%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $15.89 +2.38%
Open$16.22
Prev close$16.26
Day range$15.27 – $16.35
Volume241.5K
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-9.3x
CheapRich

Near the top of its 5-year range · 91st percentile, 5-year average -10.7x

Price / book-3.7x
CheapRich

Near the top of its 5-year range · 91st percentile, 5-year average -4.5x

P/E over five years

-15x-10x-4x1xAug '26Sep '26Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$18.99
Price vs. fair value-18.3%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -3.73 – -4.50 91% (pricier than usual) –
PE -9.26 -5.69 -10.74 91% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$18.99
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on LTGO.

Leave a comment

Scroll to Top